Pricing

Sentynl Therapeutics, Inc.

0 followers

‌

Sentynl Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases.

Industries

Life Sciences, Therapeutics

Headquarters

Solana Beach, US

Employees

11-50

Links

Org chart

Matt Heck

Founder & CEO

Matt Heck

Collapse

Darren Pincus

Senior Vice President, Business Development

Grant Castor

Senior Vice President Commercial Strategy & Operations

Eileen Banaga

Vp, Regulatory Affairs And Quality

Michael Hercz

Senior Vice President, General Counsel & Chief Compliance Officer

Jennifer Reese

Senior Vice President & Head Of Medical Affairs

Mike Cvijanovich

Senior Director Of Rare Disease Marketing

Yvonne Breugelmans Mshrm

Director Of Human Resources And Payroll

Teams

Leadership Team

6 members

Commercial Strategy and Operations

4 members

Regulatory and Compliance

3 members

Similar companies

Knoetic

4 followers

Pfizer

468 followers

Chan Zuckerberg Biohub

2 followers

bloXroute Labs

1 follower

Twenty First Group

1 follower

Essentia Analytics

1 follower

Midjourney

5 followers

Pavilion

3 followers

McKinsey & Company

490 followers

Rent.

3 followers

CVS Health

367 followers

Explore companies